Table I.
Sample | Vinorelbine concentration (μM) |
||
---|---|---|---|
0.5 hours | 2 hours | 8 hours | |
Plasma | 4.2 ± 1.3 | 1.6 ± 0.1 | 0.11 ± 0.006 |
Blood | 4.8 ± 0.9 | 1.9 ± 0.5 | 0.11 ± 0.03 |
Brain | 0.92 ± 0.15 | 0.41 ± 0.02 | 0.17 ± 0.03 |
Heart | 23.4 ± 7 | 27 ± 1.9 | 12 ± 5 |
Lung | 23 ± 3.4 | 25.5 ± 16.2 | 5.6 ± 1.3 |
Liver | 59.2 ± 15.2 | 59.3 ± 14.4 | 32.3 ± 7 |
Kidney | 74 ± 24.5 | 42 ± 4.3 | 24.5 ± 8 |
Spleen | 18 ± 3.2 | 24 ± 3.6 | 13.5 ± 5 |
Abdominal Fat | 21 ± 2.6 | 34.6 ± 9.4 | 13.5 ± 9.6 |
Large Intestine | 7.2 ± 2.9 | 11.8 ± 1.7 | 5.3 ± 2.8 |
Small Intestine | 28.5 ± 12.2 | 16.7 ± 9.4 | 9.62 ± 4.7 |
Muscle | 5.2 ± 2.5 | 5.8 ± 0.5 | 2.4 ± 0.5 |
Bone | 3.3 ± 0.8 | 4.7 ± 0.6 | 2.1 ± 1.1 |
Brain Metastases | 1.8 (0.73–6.5) | 1.7 (0.26–6.9) | 0.52 (0.14–5.8) |
Systemic Metastases | 28 (17–29) | 18.7 (5–32) |
Values represent mean ± SD (n = 3), except for metastases, where the median and range are presented